The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sclerotherapy Market Research Report 2024

Global Sclerotherapy Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1408641

No of Pages : 82

Synopsis

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.

The global Sclerotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.

This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.

Report Scope

The Sclerotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • BTG
  • Kreussler
  • LGM Pharma
  • Troikaa
  • Changan Tianyu group
  • Bioniche Pharma Group Ltd
  • Omega Pharmaceuticals
  • Angiodynamics
  • ENDO-FLEX
  • MTW ENDOSKOPIE
  • Cook Medical

Segment by Type

  • Detergents
  • Osmotic Agents
  • Chemical Irritants

Segment by Application

  • Venous Disease
  • Gastrointestinal Bleeding
  • Bronchopleural Fistula
  • Cystic Disease

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sclerotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sclerotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Market by Application
1.3.1 Global Sclerotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sclerotherapy Market Perspective (2019-2030)
2.2 Sclerotherapy Growth Trends by Region
2.2.1 Global Sclerotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sclerotherapy Historic Market Size by Region (2019-2024)
2.2.3 Sclerotherapy Forecasted Market Size by Region (2025-2030)
2.3 Sclerotherapy Market Dynamics
2.3.1 Sclerotherapy Industry Trends
2.3.2 Sclerotherapy Market Drivers
2.3.3 Sclerotherapy Market Challenges
2.3.4 Sclerotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sclerotherapy Players by Revenue
3.1.1 Global Top Sclerotherapy Players by Revenue (2019-2024)
3.1.2 Global Sclerotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sclerotherapy Revenue
3.4 Global Sclerotherapy Market Concentration Ratio
3.4.1 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sclerotherapy Revenue in 2023
3.5 Sclerotherapy Key Players Head office and Area Served
3.6 Key Players Sclerotherapy Product Solution and Service
3.7 Date of Enter into Sclerotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sclerotherapy Breakdown Data by Type
4.1 Global Sclerotherapy Historic Market Size by Type (2019-2024)
4.2 Global Sclerotherapy Forecasted Market Size by Type (2025-2030)
5 Sclerotherapy Breakdown Data by Application
5.1 Global Sclerotherapy Historic Market Size by Application (2019-2024)
5.2 Global Sclerotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sclerotherapy Market Size (2019-2030)
6.2 North America Sclerotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sclerotherapy Market Size by Country (2019-2024)
6.4 North America Sclerotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sclerotherapy Market Size (2019-2030)
7.2 Europe Sclerotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sclerotherapy Market Size by Country (2019-2024)
7.4 Europe Sclerotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sclerotherapy Market Size (2019-2030)
8.2 Asia-Pacific Sclerotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sclerotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Sclerotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sclerotherapy Market Size (2019-2030)
9.2 Latin America Sclerotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sclerotherapy Market Size by Country (2019-2024)
9.4 Latin America Sclerotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sclerotherapy Market Size (2019-2030)
10.2 Middle East & Africa Sclerotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sclerotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Sclerotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BTG
11.1.1 BTG Company Detail
11.1.2 BTG Business Overview
11.1.3 BTG Sclerotherapy Introduction
11.1.4 BTG Revenue in Sclerotherapy Business (2019-2024)
11.1.5 BTG Recent Development
11.2 Kreussler
11.2.1 Kreussler Company Detail
11.2.2 Kreussler Business Overview
11.2.3 Kreussler Sclerotherapy Introduction
11.2.4 Kreussler Revenue in Sclerotherapy Business (2019-2024)
11.2.5 Kreussler Recent Development
11.3 LGM Pharma
11.3.1 LGM Pharma Company Detail
11.3.2 LGM Pharma Business Overview
11.3.3 LGM Pharma Sclerotherapy Introduction
11.3.4 LGM Pharma Revenue in Sclerotherapy Business (2019-2024)
11.3.5 LGM Pharma Recent Development
11.4 Troikaa
11.4.1 Troikaa Company Detail
11.4.2 Troikaa Business Overview
11.4.3 Troikaa Sclerotherapy Introduction
11.4.4 Troikaa Revenue in Sclerotherapy Business (2019-2024)
11.4.5 Troikaa Recent Development
11.5 Changan Tianyu group
11.5.1 Changan Tianyu group Company Detail
11.5.2 Changan Tianyu group Business Overview
11.5.3 Changan Tianyu group Sclerotherapy Introduction
11.5.4 Changan Tianyu group Revenue in Sclerotherapy Business (2019-2024)
11.5.5 Changan Tianyu group Recent Development
11.6 Bioniche Pharma Group Ltd
11.6.1 Bioniche Pharma Group Ltd Company Detail
11.6.2 Bioniche Pharma Group Ltd Business Overview
11.6.3 Bioniche Pharma Group Ltd Sclerotherapy Introduction
11.6.4 Bioniche Pharma Group Ltd Revenue in Sclerotherapy Business (2019-2024)
11.6.5 Bioniche Pharma Group Ltd Recent Development
11.7 Omega Pharmaceuticals
11.7.1 Omega Pharmaceuticals Company Detail
11.7.2 Omega Pharmaceuticals Business Overview
11.7.3 Omega Pharmaceuticals Sclerotherapy Introduction
11.7.4 Omega Pharmaceuticals Revenue in Sclerotherapy Business (2019-2024)
11.7.5 Omega Pharmaceuticals Recent Development
11.8 Angiodynamics
11.8.1 Angiodynamics Company Detail
11.8.2 Angiodynamics Business Overview
11.8.3 Angiodynamics Sclerotherapy Introduction
11.8.4 Angiodynamics Revenue in Sclerotherapy Business (2019-2024)
11.8.5 Angiodynamics Recent Development
11.9 ENDO-FLEX
11.9.1 ENDO-FLEX Company Detail
11.9.2 ENDO-FLEX Business Overview
11.9.3 ENDO-FLEX Sclerotherapy Introduction
11.9.4 ENDO-FLEX Revenue in Sclerotherapy Business (2019-2024)
11.9.5 ENDO-FLEX Recent Development
11.10 MTW ENDOSKOPIE
11.10.1 MTW ENDOSKOPIE Company Detail
11.10.2 MTW ENDOSKOPIE Business Overview
11.10.3 MTW ENDOSKOPIE Sclerotherapy Introduction
11.10.4 MTW ENDOSKOPIE Revenue in Sclerotherapy Business (2019-2024)
11.10.5 MTW ENDOSKOPIE Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Detail
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Sclerotherapy Introduction
11.11.4 Cook Medical Revenue in Sclerotherapy Business (2019-2024)
11.11.5 Cook Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’